Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pGL4.10-Claudin-1 Citations (2)

Originally described in: Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1).
Runkle EA, Rice SJ, Qi J, Masser D, Antonetti DA, Winslow MM, Mu D J Biol Chem. 2012 Aug 17;287(34):28790-801. doi: 10.1074/jbc.M112.367987. Epub 2012 Jul 2. PubMed Journal

Articles Citing pGL4.10-Claudin-1

Articles
DOCK1 Regulates Growth and Motility through the RRP1B-Claudin-1 Pathway in Claudin-Low Breast Cancer Cells. Chiang SK, Chang WC, Chen SE, Chang LC. Cancers (Basel). 2019 Nov 8;11(11). pii: cancers11111762. doi: 10.3390/cancers11111762. PubMed
DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression. Wu JE, Wu YY, Tung CH, Tsai YT, Chen HY, Chen YL, Hong TM. Theranostics. 2020 Jul 11;10(19):8903-8923. doi: 10.7150/thno.45785. eCollection 2020. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.